戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 egulate axonal levels of the Sema3A receptor neuropilin 1.
2 moral M1, acting through the SEMA3A receptor neuropilin 1.
3 nhanced Factor Xa inhibition, and binding of neuropilin-1.
4  increased binding of VEGF to its coreceptor neuropilin-1.
5 lar endothelial growth factor receptor-2 and neuropilin-1.
6 otif Arg-Pro-Leu targets VEGF receptor-1 and neuropilin-1.
7 rted effects of tuftsin are mediated through neuropilin-1.
8 al positioning of neuronal cells, reelin and neuropilin-1.
9 was inhibited by antibodies directed against neuropilin-1.
10 ors of sensory pathfinding semaphorin 3A and neuropilin-1.
11 binds specifically to VEGF receptor-1 and to neuropilin-1.
12              The activity is blocked by anti-neuropilin-1.
13  not completely, nonoverlapping with that of neuropilin-1.
14 pecific phosphorylation in vivo, mediated by Neuropilin-1.
15 olysialylation process than those regions of neuropilin-1.
16 n into cancer cells via the interaction with neuropilin-1.
17 its impaired binding to the VEGF co-receptor neuropilin-1.
18 hrough activation of VEGF and its coreceptor neuropilin-1.
19                                              Neuropilins-1/-2 (NRP1, NRP2) are receptors for semaphor
20  of domain swap chimeras with sequences from neuropilin-1, a protein for which polysialylation had no
21 GF receptor (VEGF165R) is identical to human neuropilin-1, a receptor for the collapsin/semaphorin fa
22 r to those of others following inhibition of neuropilin-1, a receptor previously implicated in TGFbet
23 rnalized into cultured tumor cells through a neuropilin-1-activated pathway and triggered cell death.
24 finity for its primary receptor and binds to neuropilin-1, activating a tissue penetration pathway th
25    We also show that the semaphorin receptor neuropilin-1 acts cell-autonomously to control the devel
26 ration of siRNAs against the Sema3A receptor neuropilin-1 also resulted in polarization defects in vi
27     Patients with low baseline expression of neuropilin-1 also showed a trend toward improved overall
28                         Syb2 associated with Neuropilin 1 and Plexin A1, two essential components of
29 izes the extrinsic pathway and requires both neuropilin 1 and plexin A3.
30 ways by antibodies to neuropilin-1, and that neuropilin-1 and -2 can form homo- and heterooligomers t
31 jections in vivo correspond to those seen in Neuropilin-1 and -2 mutants.
32 opilin-2 oligomers, and the Sema E signal by neuropilin-1 and -2, either as homo- or heterooligomers.
33 is, we show that sympathetic axons coexpress neuropilin-1 and -2, that their responses to Sema III, S
34 inity antagonist, TKPPR, bind selectively to neuropilin-1 and block vascular endothelial growth facto
35 ded to associated cues of axon guidance like neuropilin-1 and F-actin.
36     First, aged Tregs had high expression of neuropilin-1 and Helios, and had a broad Vbeta repertoir
37 naling by a mechanism that is independent of neuropilin-1 and heparan sulfate proteoglycans.
38 pecific genes including VEGFR-3, FGFR-3, and neuropilin-1 and is required along with Prox1 to maintai
39 PDC secretion of IFN-alpha and expression of Neuropilin-1 and MHC I.
40                                              Neuropilin-1 and neuropilin-2 bind differentially to dif
41                                              Neuropilin-1 and neuropilin-2 show specificity in bindin
42 l repellents that cause repulsion by binding Neuropilin-1 and Neuropilin-2, respectively.
43   Furthermore, the Sema3A receptor proteins, neuropilin-1 and plexin, and the Sema3A signaling molecu
44 1 involves heparan sulfate proteoglycans and neuropilin-1 and results in long-term productive infecti
45 A and Slit2, and their respective receptors, Neuropilin-1 and Robo2.
46 ng of VEGF to low-affinity binding sites and neuropilin-1 and stimulates further growth factor recept
47  also upregulated VEGFR2 and its co-receptor neuropilin-1 and suppressed the expression of semaphorin
48 iven the overlap between processes involving neuropilin-1 and tuftsin, we propose that at least some
49 th factor A (VEGF-A) isoforms, expression of neuropilin-1 and VEGF receptor 1 in tumors or plasma, an
50 c vessel endothelial hyaluronan receptor 1), neuropilin-1 and VEGFR2 (vascular endothelial growth fac
51 force sensor and forms a mechanocomplex with neuropilin-1 and VEGFR2 that is necessary and sufficient
52                          The arterial marker neuropilin-1 and venous marker EphB4 are ectopically exp
53  this study, we produced a variety of mutant neuropilin-1s and tested their cell adhesion activity.
54                                          The neuropilins-1 and -2 (NRP1 and NRP2) function as recepto
55 iple combination of selection markers--CD34, neuropilin 1, and human kinase insert domain-containing
56 ication of sialoglycoproteins such as CD105, neuropilin-1, and CLEC14A, which have already been descr
57  (VEGF) and three of its receptors, VEGFR-2, neuropilin-1, and neuropilin-2, in paraffin-embedded sam
58  affected in predicted ways by antibodies to neuropilin-1, and that neuropilin-1 and -2 can form homo
59 omologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a gr
60 ate the role of a potential guidance factor, neuropilin-1, and use functional knockdown assays, tissu
61 mplex of chondroitin C sulfate proteoglycan, neuropilin-1, and VEGF receptor-2, overexpressed togethe
62 wth factor-A (VEGF-A), protein expression of neuropilin-1, and VEGF receptors-1 and -2 (VEGFR-1 and V
63 tivity of the CgA(1-373) was blocked by anti-neuropilin-1 antibodies as well as by nicotinic acetylch
64             Moreover, mice treated with anti-neuropilin-1 antibodies exhibited a significant decrease
65  IV repulsive response, and these domains of neuropilin-1 are necessary and sufficient for binding of
66               In conclusion, flt-1, KDR, and neuropilin-1 are present on cultured HMC, and VEGF(165)
67                      Plasma VEGF-A and tumor neuropilin-1 are strong biomarker candidates for predict
68 merulus, and VEGF receptors (flt-1, KDR, and neuropilin-1) are present on endothelial cells and other
69 aging, as well as suggest miR-208a, AT2R and neuropilin 1 as potential therapeutic targets and mechan
70                                We identified neuropilin-1 as a mediator of cancer cell invasion by a
71  of TKPPR had greatly increased affinity for neuropilin-1 based on competition binding experiments.
72                        Investigation of PlGF/Neuropilin-1 binding and function suggests a critical ro
73 matically removed in plasma, causing loss of neuropilin-1 binding and gain of antiangiogenic activity
74                 Third, in endothelial cells, neuropilin-1 binds a potent endothelial cell mitogen, va
75                   Second, in neuronal cells, neuropilin-1 binds the class 3 semaphorins, which are ne
76 invasion in vitro and that the VEGF receptor Neuropilin-1 but not Flt-1 is essential for this functio
77 expressed the mRNA for VEGF receptor (VEGFR) neuropilin-1 but not the VEGFRs Flt-1 or KDR.
78 t HN33 cells expressed VEGFR-2 receptors and neuropilin-1, but not VEGFR-1 receptors.
79 he generation of a dominant negative form of neuropilin-1 by the deletion of one of its extracellular
80                                      Lastly, neuropilin-1 can homomultimerize and form heteromultimer
81                      The model predicts that Neuropilin-1 can induce differences in the surface-to-in
82  express similar levels of Sema3A receptors (neuropilin-1, cell adhesion molecule L1, and plexinA4),
83 Factor (VEGF)-dependent, proangiogenic GIPC1-Neuropilin 1 complex, recasting GIPCs as negative modula
84               Mice with Treg cell-restricted Neuropilin-1 deficiency show tumor resistance while main
85 nd tLyP-1 internalize into cells through the neuropilin-1-dependent CendR internalization pathway.
86  tissue permeability in a tumor-specific and neuropilin-1-dependent manner, allowing coadministered d
87 ema3A decreases cell-substrate adhesion in a neuropilin-1-dependent manner.
88          When coexpressed in cells with KDR, neuropilin-1 enhances the binding of VEGF165 to KDR and
89 th, portal vessels undergo a transition from Neuropilin-1(+)Ephrin-B2(+) artery to EphB4(+) vein phen
90  CI, 0.59 to 0.97) versus patients with high neuropilin-1 expression (HR, 1.07; 95% CI, 0.81 to 1.40;
91                                              Neuropilin-1 expression in anergic conventional CD4(+) T
92                                     Although neuropilin-1 expression in GBMs was previously shown, it
93      Baseline plasma VEGF-A levels and tumor neuropilin-1 expression were identified as potential pre
94                  Though the binding sites in neuropilin-1 for the class 3 semaphorins and VEGF(165) h
95                                         When neuropilin-1 function is knocked down in ovo, neural cre
96         Interestingly, with the reduction of neuropilin-1 function, neural crest cells still form seg
97 tract region that are attenuated by blocking neuropilin-1 function.
98 ls of multiple genes and proteins (including Neuropilin 1, glucocorticoid-induced tumor necrosis fact
99 crease in the pTreg to CD4(+)CD25(+)Foxp3(+) neuropilin-1(high) thymic Treg ratio by day 10.
100  study highlights the proangiogenic receptor neuropilin 1 in macrophages and microglial cells in glio
101       A novel role for myeloid cell-specific neuropilin 1 in mitigating sepsis.
102 the translation of the guidance cue receptor Neuropilin-1 in RGCs, with Hermes knock-down resulting i
103 er, that sensory neurons are able to express neuropilin-1 in the absence of Brn3a.
104 hosphorylation status and down-regulation of neuropilin-1 in the HemSCs demonstrate that VEGFR-2 and
105  and in vivo evidence for a critical role of neuropilin-1 in wound angiogenesis.
106 giogenic receptors (alphavbeta3 integrin and neuropilin-1) in vitro as well as in vivo.
107 e transfer experiments and the expression of neuropilin-1 indicate that these cells are predominantly
108 rent iNKT subsets defined by CD4, NK1.1, and neuropilin-1, indicating that distinct functional subpop
109 Conversely, inhibition of VEGF165 binding to neuropilin-1 inhibits its binding to KDR and its mitogen
110 s a critical role for heparin-binding domain/Neuropilin-1 interaction and its regulation by plasmin p
111                   These results suggest that neuropilin-1 is a necessary component of receptor comple
112                              We propose that neuropilin-1 is a novel VEGF receptor that modulates VEG
113                                              Neuropilin-1 is a receptor for Sema III.
114                                              Neuropilin-1 is a receptor for semaphorin3A (Sema3A), a
115                                              Neuropilin-1 is a type 1 membrane protein with three dis
116         The cAMP-dependent guidance receptor neuropilin-1 is also lost from beta3GnT2(-/-) OSNs and a
117                                              Neuropilin-1 is expected to form complexes with the plex
118 irement for these two Plexins: signaling via Neuropilin-1 is mediated principally by Plexin-A4, where
119  surprise, we found that membrane-associated neuropilin-1 is polysialylated at approximately 50% of t
120 vation and RNA interference , we showed that neuropilin-1 is required for GBM cell migration.
121 action between fragmented chromogranin A and neuropilin-1 is required for tumor growth and represents
122                         Sema3A, a ligand for neuropilin-1, is effective in repelling geniculate and t
123 rain regions and a receptor for collapsin-1, neuropilin-1, is expressed by migrating crest cells deri
124  a recently identified co-receptor for VEGF, neuropilin-1, is not well understood.
125                                          The neuropilin-1 ligand placenta growth factor-2 failed to r
126 ound was driven by the CD4(+)CD25(+)Foxp3(+) neuropilin-1(low) peripheral Treg (pTreg), resulting in
127                                              Neuropilin-1 maintains dimethylarginine dimethylaminohyd
128               An alternate VEGFR, VEGFR-1 or neuropilin-1, may modulate adhesion of leukocytes to tum
129 istic insights into the regulation of PlGF-2/Neuropilin-1-mediated tissue vascularization and growth.
130 blastic cells (MC3T3-E1) expressed Flt-1 and neuropilin-1 mRNA but not KDR.
131 actor (VEGF), VEGF receptors, semaphorin 3F, neuropilin 1, neuropilin 2, podoplanin, and LYVE-1 by qu
132 evels of known A10 elevated genes, including neuropilin 1, neuropilin 2, slit2 and adenylyl cyclase-a
133 ctor to its heterodimeric receptor--Flk1 and neuropilin 1 (NP-1; also called Nrp1)--activates the Not
134                                              Neuropilin-1 (NP-1) has been identified as a necessary c
135                                              Neuropilin-1 (NP-1) is a component of the receptor for s
136                        Further, we show that neuropilin-1 (NP-1) mediates both PS-dependent and PS-in
137                                              Neuropilin-1 (NP-1) was first identified as a semaphorin
138                                              Neuropilin-1 (Np-1), a receptor for semaphorin 3A and va
139 orin-binding proteins, plexin 1 (Plex 1) and neuropilin-1 (NP-1), form a stable complex.
140 t and are linked to tumor cell expression of neuropilin-1 (Np-1).
141              Semaphorin 3A (Sema3A) binds to neuropilin-1 (NP1) and activates the transmembrane Plexi
142                                              Neuropilin-1 (NP1), in conjunction with plexins, promote
143                                              Neuropilin-1 (Npn-1) is a cell surface receptor that bin
144                                              Neuropilin-1 (Npn-1) is a receptor for both semaphorin 3
145                                              Neuropilin-1 (Npn-1) is a receptor that binds multiple l
146                               Interestingly, neuropilin-1 (Npn-1) is expressed by periocular neural c
147 escribed VEGF(165) isoform-specific receptor neuropilin-1 (Npn-1) is responsible for the difference i
148                                              Neuropilin-1 (Npn-1), a receptor for semaphorin III, med
149 otein that has chemorepulsive properties for neuropilin-1 (npn-1)- expressing axons.
150 ding of Sema3A to its high-affinity receptor Neuropilin-1 (Npn-1).
151 ble semaphorin D (semD) binds to growth cone neuropilin-1 (Npn-1).
152 L1) and the semaphorin 3A (Sema3A) receptor, neuropilin 1 (Npn1), important for establishment of area
153 ssed in the lens epithelium and its receptor Neuropilin-1 (Npn1) is expressed in the trigeminal gangl
154                     We provide evidence that Neuropilin 1 (Nrp-1), highly expressed by Foxp3(+) T reg
155 RPPR peptide, with affinity for the receptor neuropilin-1 (NRP), which is expressed on both endotheli
156 alpha(cont) and Gsalpha(KO) cells identified neuropilin-1 (Nrp-1) and granulin (Grn) as osteocytic-se
157 rived GBM cells expressing shRNAs of VEGF or neuropilin-1 (NRP-1) attenuate cancer stem cell markers,
158 that must be C-terminally exposed to trigger neuropilin-1 (NRP-1) binding, cellular internalization a
159                 Instead, VEGF-A acts via the neuropilin-1 (NRP-1) co-receptor.
160 eport that expression of the VEGF coreceptor neuropilin-1 (NRP-1) coincides with expression of Brachy
161 actor (VEGF) and semaphorin-binding receptor Neuropilin-1 (Nrp-1) emerge as crucial determinants of M
162                     An increased staining of neuropilin-1 (NRP-1) further showed a transformation cha
163                                              Neuropilin-1 (NRP-1) has been found to be expressed by e
164                                Expression of neuropilin-1 (NRP-1) has been shown in many cancer cells
165 tosis transport pathway that is regulated by neuropilin-1 (NRP-1) has recently been reported.
166    Heparin/heparan sulfate proteoglycans and neuropilin-1 (NRP-1) have been identified as co-receptor
167 gated the role of semaphorin 3A (Sema3A) and neuropilin-1 (Nrp-1) in lymphatic vessel maturation and
168                                              Neuropilin-1 (NRP-1) is a type 1 membrane protein that b
169  that trafficking of the angiogenic receptor neuropilin-1 (NRP-1) is abrogated by the liver kinase B1
170 raphy showed that the CendR peptides bind to neuropilin-1 (NRP-1) on the target cells.
171 essing a conditional deletion of endothelial neuropilin-1 (Nrp-1) or in wild-type mice systemically t
172                         Here, we report that neuropilin-1 (NRP-1) orchestrates communications between
173                              One targets the neuropilin-1 (NRP-1) receptors of cancer cells through t
174 xpression of VEGF and VEGF receptors KDR and neuropilin-1 (NRP-1) was detected in these cells.
175                                              Neuropilin-1 (NRP-1) was first described as a coreceptor
176                                    Recently, neuropilin-1 (NRP-1) was reported to bind and activate t
177 liver fibrosis, the axonal guidance molecule neuropilin-1 (NRP-1) was upregulated in activated HSCs,
178 , heparan sulfate proteoglycans (HSPGs), and neuropilin-1 (NRP-1) were demonstrated to facilitate HTL
179  and conditional knockout mice, we show that neuropilin-1 (NRP-1), a known receptor of VEGF, is neces
180                 As a model, we have targeted neuropilin-1 (NRP-1), a membrane-bound receptor expresse
181                                              Neuropilin-1 (NRP-1), a recently identified co-receptor
182 we demonstrate that a cell surface molecule, neuropilin-1 (Nrp-1), is expressed at high levels on nT
183 vation of both VEGF receptor 2 (VEGFR-2) and neuropilin-1 (Nrp-1), since neutralizing antibodies to e
184 th heparan sulfate proteoglycans (HSPGs) and neuropilin-1 (NRP-1), two molecules important for HTLV-1
185 s mediated through a molecular cross-talk of neuropilin-1 (NRP-1), VEGFR1 (Flt-1), and phosphoinositi
186                                We found that Neuropilin-1 (Nrp-1), which is expressed by most Treg ce
187                                  We identify Neuropilin-1 (NRP-1)-mediated activation of KDR signalin
188 emma vesicle-associated protein-1 (PV-1) and neuropilin-1 (NRP-1).
189 h through interaction with the VEGF receptor neuropilin-1 (NRP-1).
190 g receptor as the transmembrane glycoprotein neuropilin-1 (NRP-1).
191 n exposed site within the b1 domain of human neuropilin-1 (NRP-1).
192 actions with alphavbeta3/beta5 integrins and neuropilin-1 (NRP-1).
193 if with cell-and tissue penetration receptor neuropilin-1 (NRP-1).
194 progression by binding with its co-receptor, neuropilin-1 (NRP-1).
195 ead, we found that ANGPTL4 binds directly to neuropilin 1 (NRP1) and NRP2 on endothelial cells (ECs),
196                            Here we show that Neuropilin 1 (Nrp1) and Nrp2, transmembrane proteins wit
197  BMA nucleus, owing to reduced expression of neuropilin 1 (Nrp1) and Nrp2, two semaphorin receptors t
198      VEGF165 binds the transmembrane protein neuropilin 1 (NRP1) and promotes the migration, survival
199 mall molecule ligand for the VEGF-A receptor neuropilin 1 (NRP1) and the structural characterization
200  demonstrate that beta8 integrin (Itgb8) and neuropilin 1 (Nrp1) cooperatively promote CNS angiogenes
201   Moreover, high expression of PlGF receptor neuropilin 1 (Nrp1) correlates with poor overall surviva
202                            Here we show that neuropilin 1 (NRP1) directly interacts with EBV gB(23-43
203 tion, bevacizumab decreased Ang1 and induced neuropilin 1 (NRP1) expression in tumor-associated macro
204 semaphorin SEMA3C, and their shared receptor neuropilin 1 (NRP1) in OFT development, the precise mech
205                                              Neuropilin 1 (NRP1) is a receptor for class 3 semaphorin
206                                              Neuropilin 1 (NRP1) is a transmembrane glycoprotein that
207                                              Neuropilin 1 (Nrp1) is a type I transmembrane protein th
208                          We report here that Neuropilin 1 (Nrp1) is expressed at high levels by most
209                                              Neuropilin 1 (NRP1) plays an important but ill-defined r
210  analyses with in vitro assays, we show that neuropilin 1 (NRP1) promotes contralateral RGC projectio
211  of GlyRS, enabling GlyRS(CMT2D) to bind the neuropilin 1 (Nrp1) receptor.
212  by endothelial cells where it partners with neuropilin 1 (Nrp1) to form a functional receptor for th
213           The transmembrane receptor protein neuropilin 1 (Nrp1) was recently identified as an aberra
214                                              Neuropilin 1 (Nrp1), a coreceptor for class 3 semaphorin
215               Moreover, TAOK2 interacts with Neuropilin 1 (Nrp1), a receptor protein that binds the s
216              Emerging evidence suggests that neuropilin 1 (Nrp1), an originally defined coreceptor fo
217 ssel growth, endothelial cells (ECs) express neuropilin 1 (NRP1), and NRP1 associates with the recept
218 f these targets is the guidance cue receptor Neuropilin 1 (Nrp1), which is sensitive to the repellent
219                     However, the addition of neuropilin 1 (Nrp1)-blocking antibody or siRNA knockdown
220 e identified the LD22-4 membrane receptor as neuropilin 1 (NRP1).
221                                              Neuropilin-1 (NRP1) and neuropilin-2 (NRP2) are both rec
222                                              Neuropilin-1 (NRP1) and NRP2 are cell surface receptors
223 ule (CendR) motif that binds to cell surface neuropilin-1 (NRP1) and NRP2 receptors.
224 ein binds to lymphatic valves expressing the Neuropilin-1 (Nrp1) and PlexinA1 receptors.
225            VEGF receptors VEGFR1, VEGFR2 and Neuropilin-1 (NRP1) are mostly in 'Free State'.
226 ass spectrometry-based approach, we identify neuropilin-1 (NRP1) as a NE receptor that mediates uptak
227 n part, on signaling through the VEGF-VEGFR2-Neuropilin-1 (NRP1) axis.
228                        In endothelial cells, neuropilin-1 (NRP1) binds vascular endothelial growth fa
229 rt that mice with a CD8(+) T cell-restricted neuropilin-1 (NRP1) deletion exhibited substantially enh
230                                              Neuropilin-1 (NRP1) functions as a coreceptor through in
231                                              Neuropilin-1 (Nrp1) guides the development of the nervou
232 has implicated the transmembrane co-receptor neuropilin-1 (NRP1) in cancer progression.
233 efine the role of transmembrane glycoprotein neuropilin-1 (NRP1) in the expression of DDAHs and inves
234 Sema4a) and the Treg-cell-expressed receptor neuropilin-1 (Nrp1) interact both in vitro, to potentiat
235                                              Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor
236                                              Neuropilin-1 (Nrp1) is a cell surface molecule originall
237                                              Neuropilin-1 (NRP1) is a cell-surface receptor for both
238                                              Neuropilin-1 (NRP1) is a coreceptor for multiple extrace
239                                              Neuropilin-1 (NRP1) is a coreceptor to a tyrosine kinase
240                                              Neuropilin-1 (NRP1) is a receptor for two unrelated liga
241                                              Neuropilin-1 (NRP1) is a VEGF(165) and semaphorin recept
242                                              Neuropilin-1 (Nrp1) is an essential receptor for angioge
243                                              Neuropilin-1 (NRP1) is an essential transmembrane recept
244                                              Neuropilin-1 (NRP1) is expressed by endothelial cells an
245                                              Neuropilin-1 (Nrp1) is required to maintain intratumoral
246 tion of circulating monocytes expressing the neuropilin-1 (Nrp1) receptor (Nrp1-expressing monocytes;
247  onset of Sema3A sensitivity and concomitant neuropilin-1 (NRP1) receptor expression and caused cell-
248                                              Neuropilin-1 (NRP1) was first described as a receptor fo
249                                              Neuropilin-1 (NRP1), a cell-surface receptor for both va
250                                              Neuropilin-1 (NRP1), a non-tyrosine kinase receptor, is
251 ligo G) reduce endothelial levels of surface neuropilin-1 (NRP1), a receptor shared by semaphorin 3A
252                    Here, we demonstrate that neuropilin-1 (NRP1), a Semaphorin receptor expressed in
253                 In this study, we found that neuropilin-1 (NRP1), known to bind furin-cleaved substra
254 disrupts the developmental downregulation of Neuropilin-1 (Nrp1), the receptor for Sema3A, in sensory
255                                              Neuropilin-1 (NRP1), which is a critical receptor implic
256    Mice that lack the transmembrane receptor neuropilin-1 (Nrp1), which modulates GAM immune polariza
257 e show this is a key endothelial function of neuropilin-1 (Nrp1), which suppresses the stalk-cell phe
258                                          The neuropilin-1 (NRP1)-MET signaling axis regulates the mot
259  Semaphorin3A (Sema3A) which both signal via neuropilin-1 (Nrp1).
260 dritic cell (pDC) marker, BDCA4, identifying neuropilin-1 (NRP1); and the helper T cell marker, CD4.
261 microenvironment by increasing the levels of neuropilin-1 (NRP1, a co-receptor of vascular endothelia
262 Sema III signal is mediated predominantly by neuropilin-1 oligomers, the Sema IV signal by neuropilin
263              Importantly, deletion of either neuropilin 1 or plexin A3 significantly reduces developm
264                     Sema K1 does not bind to neuropilin-1 or neuropilin-2, the two receptors implicat
265  that VEGF immobilization, interactions with Neuropilin-1, perturbations of VEGFR2 trafficking, and c
266 gesting that these receptors, in addition to neuropilin-1, play a role in the proangiogenic activity
267 esults support that Farp1 interacts with the Neuropilin-1/PlexinA1 complex and colocalizes with Plexi
268  that SEMA3A acts as a potent attractant for neuropilin-1-positive (NRP-1-positive) MPs.
269 pment and is not required for maintenance of neuropilin-1-positive natural Tregs in the periphery, it
270                 MAOA-dependent activation of neuropilin-1 promoted AKT/FOXO1/TWIST1 signaling, allowi
271 omprising 70% neuropilin 1(+) tTregs and 30% neuropilin 1(-) pTregs.
272 hat lung cancers (n = 34) always express the neuropilin-1 receptor for secreted semaphorins, whereas
273  neurons transduce this signal by way of the neuropilin-1 receptor.
274 owed slightly decreased binding to the NRP1 (neuropilin-1) receptor, and analyses suggested the hepar
275  stemmed from a failure to expand functional neuropilin-1(+) regulatory T (T reg) cells in the absenc
276  L1 and modulating the endocytosis of the L1/neuropilin 1 Sema3A receptor complex.
277 e adhesion and suggest that targeting Sema3A-neuropilin-1 signaling may limit GBM infiltration.
278 ar tumor areas is regulated by Semaphorin 3A/Neuropilin-1 signaling; interference with this pathway e
279                       Specific inhibition of neuropilin-1 significantly reduced CNS vascular permeabi
280                Time-lapse imaging shows that neuropilin-1 siRNA transfected neural crest cells stop a
281 betic female rats have reduced expression of neuropilin 1 that attenuates cardiomyopathy compared to
282 hat the misexpression of a dominant-negative neuropilin-1 that blocks SEMA-3A-mediated signaling in o
283                          A truncated form of neuropilin-1 that is missing its cytoplasmic domain fail
284 dipocytes, probably through up-regulation of neuropilin-1, the OB-mediated enhanced hematopoiesis fun
285 he precursor, bound the VEGF-binding site of neuropilin-1; the C-terminal arginine (R(373)) of the se
286 tor complex comprising VEGFR2, PlexinD1, and neuropilin-1, thereby preventing degradation of internal
287                Specifically, pDCs upregulate neuropilin-1 to enable the long term interactions of pDC
288  for by exon 8 may stabilize VEGF binding to neuropilin-1 to facilitate signaling through VEGFR-2.
289  implicate Sema3A as an autocrine signal for neuropilin-1 to promote GBM dispersal by modulating subs
290  uterus-draining lymph nodes, comprising 70% neuropilin 1(+) tTregs and 30% neuropilin 1(-) pTregs.
291 h 2 (ba2), is due to chemoattraction through neuropilin-1-vascular endothelial growth factor (VEGF) i
292 pendent on chemoattractive signaling through neuropilin-1-VEGF interactions.
293 r involved signaling through VEGF receptor 2-neuropilin 1 (VEGFR2-NP1) receptors on endometrial strom
294  model of dermal wound repair, we found that neuropilin-1 was abundantly expressed on new vasculature
295  VEGF-A in endothelial cells, and coreceptor neuropilin-1 was significantly decreased in Dll4-transdu
296  dHAND-null hearts), the VEGF(165) receptor, neuropilin-1, was found to be downregulated in dHAND mut
297 onstrated that the cell adhesion ligands for neuropilin-1 were proteins and distributed in embryonic
298  domains within the extracellular segment of neuropilin-1 were required for the cell adhesion activit
299                                       Unlike neuropilin-1, which binds with high affinity to the thre
300 njugate (a peptide that binds to the protein neuropilin-1, which is highly expressed in tumours, and

 
Page Top